Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
about
Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalitiesRett Syndrome: Crossing the Threshold to Clinical TranslationToxoplasma Gondii Moderates the Association between Multiple Folate-Cycle Factors and Cognitive Function in U.S. Adults.Perceptual learning in Williams syndrome: looking beyond averages.The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasisIncreasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient miceBreathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birthNeurobiologically-based treatments in Rett syndrome: opportunities and challenges.Genetic diseases: congenital central hypoventilation, Rett, and Prader-Willi syndromes.Clinical, etiological and therapeutic aspects of cerebral folate deficiency.Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity.Trihexyphenidyl for acute life-threatening episodes due to a dystonic movement disorder in Rett syndrome.S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid in Rett syndrome and the effect of folinic acid supplementation.Loss of MeCP2 in adult 5-HT neurons induces 5-HT1A autoreceptors, with opposite sex-dependent anxiety and depression phenotypes.
P2860
Q24652603-495AF986-43E8-4FB7-8C9F-DC3F1671E1F1Q26772909-126B2938-8D7E-4A52-AC58-2533A355C378Q33851885-DC7F2D87-14E0-4E10-8317-D0F6EBF14B5BQ34336089-C26E6B19-74A5-4DFA-9AFF-AFA23765D134Q35098779-36E71781-8B64-45B5-97D1-70F0E4A0525FQ36968088-480D764F-570B-4F45-ABA7-A701FAC393B6Q37379871-810DCF9A-1F6B-40CC-9679-F26A9AE4594AQ37558440-6B31665F-F571-44F7-9887-B962ADA935F8Q38110760-8F1863B4-709A-49DA-A66B-C244A09275D4Q38532628-7E443A05-EE6F-485F-98C9-D21B77DC4D1BQ39557159-09C4D6C5-CC95-4670-B833-E61577FA6CA1Q43197911-C48DFCB2-EA9B-42CF-90ED-AAC6854F44E1Q43490311-B2989B4F-DE6C-4334-909D-46B06D24D407Q52595326-E39B1945-5FD1-4307-9826-AB2912F38B5D
P2860
Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@en
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@nl
type
label
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@en
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@nl
prefLabel
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@en
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@nl
P2093
P1476
Evaluation of CSF neurotransmi ...... rder and effects of treatment.
@en
P2093
A Ormazabal
I Carrilho
J Monteiro
J P Vieira
J Sequeiros
P356
10.1016/J.BRAINDEV.2008.05.003
P577
2008-06-24T00:00:00Z